Murata Vios
- Company typePrivate
- Founded2012
- HeadquartersSaint Paul, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Murata Vios firmographics
Firmographics- Name
- Murata Vios
- Legal name
- Murata Vios, Inc.
- Website
- https://viosmedical.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
Murata Vios industry classification
Industry- Product category
- Wireless Patient Monitoring (Medical Devices)
- NAICS
- Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Other Measuring and Controlling Device Manufacturing (334519)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845), Measuring & Controlling Devices, Nec (3829)
- akta.pro primary industry
- Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration) (HLACAPAI)
- akta.pro secondary industries
- Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous) (HLAHACAA), Remote Diagnostics & Point-of-Care (Connected Testing, Home Lab Devices) (HLACAPAK)
Keywords
Where Murata Vios is headquartered
LocationHeadquarters
- HQ city
- Saint Paul
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Murata Vios business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Subscription/Monitoring Services: Monthly subscription model offering fixed, all-inclusive low monthly payment. Includes remote monitoring services by certified ECG technicians providing 24/7 oversight. Cap-Ex and Op-Ex programs available for different institution needs.
- Hardware Sales: Sale of Vios Monitoring System components including chest sensors, bedside monitors, and central station monitors. Reusable sensor hardware helps control ongoing program costs.
- Remote Patient Monitoring (RPM) Reimbursement: The VMS may be reimbursable based on Remote Patient Monitoring (RPM) CPT codes published by CMS. Company provides tools and information for validation by Medical Billing Teams.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Monthly Subscription Model - Fixed all-inclusive payment |
| Other | Multi-year contract | Cap-Ex Program - Capital Expenditure Option |
| Subscription | Monthly | Op-Ex Program - Operational Expenditure Option |
Distribution channels3 records
Marketing channels7 records
Murata Vios product offering
Product offeringCore offering
Murata Vios designs, manufactures, and sells the FDA-cleared Vios Monitoring System (VMS), a wireless platform comprising a Chest Sensor, Bedside Monitor, Central Station Monitor, and Central Server (cloud software) that delivers continuous 7-lead ECG, heart rate, respiratory rate, SpO2, pulse rate, posture, and Continuous Non-Invasive Blood Pressure (CNIBP) monitoring in post-acute care settings. The company also operates the Vios Monitoring Program — combining the hardware platform with 24/7 remote monitoring by AHA-certified ECG technicians — and offers separate Remote Monitoring Services to offload alarm surveillance from clinical staff in skilled nursing facilities, inpatient rehabilitation hospitals, ketamine clinics, and hospitals.
Product overview
Murata Vios offers the Vios Monitoring System (VMS), a unified wireless patient monitoring platform consisting of four hardware components—the Chest Sensor, Bedside Monitor (BSM), Central Station Monitor (CSM), and Central Server with cloud software—integrated with Remote Monitoring Services staffed by AHA-certified technicians. The system delivers hospital-grade 7-lead ECG telemetry, continuous vital signs monitoring (heart rate, respiratory rate, SpO2, pulse rate, posture), and automated data integration into PointClickCare EHR. The Vios Monitoring Program is the service offering combining this hardware/software platform with 24/7 remote monitoring by certified ECG technicians to prevent hospital readmissions in post-acute care settings. Additional offerings include Vios University training platform and specialized Ketamine Clinic Monitoring Solution modules.
Differentiator
Problem solved
Functional benefit
Products and services
- Vios Monitoring System (VMS) Wireless, FDA-cleared IoT patient monitoring platform that continuously monitors 7-lead ECG, heart rate, respiratory rate, SpO2, pulse rate, and posture. Integrates the Chest Sensor, Bedside Monitor (BSM), Central Station Monitor (CSM), and cloud-hosted Central Server into a unified monitoring platform for post-acute care facilities.
- Vios Monitoring Program Integrated program bundling the Vios Monitoring System with 24/7 remote monitoring by AHA-certified ECG technicians to deliver hospital-grade cardiac telemetry, continuous vital signs data, and intervention support that prevents hospital readmissions in post-acute care settings including inpatient rehabilitation hospitals, skilled nursing facilities, and ketamine clinics.
- Remote Monitoring Services AHA-certified remote monitoring technicians provide 24/7/365 patient oversight, alert designated staff of any change in patient condition, and alleviate staffing burden by handling continuous surveillance. Offered as either an in-house monitoring option or Vios-provided monitoring service layered on top of the Vios Monitoring System.
- Ketamine Clinic Monitoring Solution Specialized monitoring offering for ketamine infusion clinics featuring the FDA-cleared Continuous Non-Invasive Blood Pressure (CNIBP) algorithm, real-time cardiac monitoring, respiratory rate and SpO2 tracking, and centralized multi-treatment-room oversight with reusable sensor hardware and customizable alerts.
Quantifiable outcome
- Up to 25% of hospital readmissions are preventable with earlier recognition and intervention
- +3 more outcomes
Companies that use Murata Vios
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles4 records
Murata Vios technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
AI capability1 record
Feature6 records
Murata Vios partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core, major and flagship.
- NADONA (National Association of Directors of Nursing Administration in Long Term Care)coreStrategic partnership for co-branded educational webinars on cardiac telemetry and continuous vital signs monitoring in post-acute care. NADONA is a leading association for nurse leaders in long-term and post-acute care.
- Skilled Nursing News (SNN)majorPartnership for Demo Day webinar hosting and co-marketing content around patient outcomes and continuous vital signs monitoring. Skilled Nursing News is a leading news source for the skilled nursing sector.
- PointClickCarecoreIntegration partnership to improve how healthcare facilities capture and integrate continuous vital signs monitoring data into resident electronic health records. The Vios Monitoring System with PointClickCare integration enables seamless uploading of patient data to EHR platform.
- Murata ManufacturingflagshipVios Medical was acquired in 2017 by Murata Manufacturing, the world's market leader in electronics components. Murata provides global leadership in electronics innovation, reliable product performance, and world-class service and support. Murata has strong presence in the United States and is expanding focus on medical products as part of broader healthcare innovation commitment.
Scale indicators6 records
Recent moves4 records
Expansion highlights5 records
Murata Vios competitors and assessment
Company assessmentDirect peers
- Masimo: Masimo's SET pulse oximetry and patient-worn monitoring (Radius-7, Rad-G) overlap with Vios's continuous SpO2 and wearable vitals monitoring for in-hospital and post-acute use. Comparable FDA-cleared continuous monitoring with similar clinical value propositions around early deterioration detection.
- VitalConnect: VitalConnect's Vista Solution offers a wearable, FDA-cleared, continuous vital signs monitoring patch with cardiac and respiratory monitoring. Directly comparable to Vios's chest sensor in form factor, modality, and post-discharge / outpatient use case.
- EarlySense: EarlySense's contact-free under-mattress continuous monitoring sensor tracks heart rate, respiratory rate, and motion for hospital and skilled nursing facility patients. Comparable in targeting the post-acute and SNF market for early deterioration detection with continuous vital signs.
- Sotera Wireless (ViSi Mobile): Sotera Wireless's ViSi Mobile is a wrist-worn continuous vital signs monitor used in general care and step-down hospital settings. Directly comparable to Vios on continuous multi-parameter monitoring of ambulatory patients with alarm management capabilities.
Broad incumbents
- Philips (Patient Monitoring): Philips IntelliVue and wearable biosensor solutions are the dominant hospital-grade patient monitoring platforms globally. Overlaps with Vios on continuous ECG telemetry and vital signs monitoring, but serves a much broader ICU and step-down footprint and is now extending downmarket into post-acute settings.
- Mindray: Mindray is a global patient monitoring and medical device manufacturer offering telemetry and bedside monitors across acuity levels. Competes with Vios on continuous ECG and multi-parameter vital signs monitoring across hospital and post-acute settings, particularly on price-sensitive accounts.
- Nihon Kohden: Nihon Kohden is a major patient monitoring vendor with telemetry and bedside monitors used in hospitals and increasingly in alternative care settings. Overlaps with Vios on continuous cardiac telemetry, NIBP, and SpO2 monitoring.
- Medtronic (Cardiac Diagnostics): Medtronic's Cardiac Diagnostics portfolio (including LINQ insertable cardiac monitors and SEEQ MCT) overlaps with Vios on continuous cardiac monitoring, though Medtronic focuses more on ambulatory ECG diagnostics and remote monitoring services infrastructure.
- GE HealthCare (CARESCAPE): GE's CARESCAPE patient monitoring portfolio competes directly in continuous ECG, NIBP, and SpO2 across hospital care settings. Vios differentiates by targeting post-acute rather than ICU, but GE has the scale to expand into adjacent care settings.
- Baxter (Hillrom / Voalte): Baxter acquired Hillrom, whose patient monitoring portfolio (including the previously connected Voalte acquisition) serves both hospital and post-acute environments. Competes with Vios in continuous monitoring and workflow integration for skilled nursing and rehab facilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Murata Vios social profiles
Digital presenceMurata Vios compliance and trust
Trust signalCompliance4 records
Murata Vios financial estimates
Financial estimateRevenue estimate
Valuation estimate
Murata Vios leadership team
Management profileNumber of profiles
Profiles3 records
Murata Vios funding detail
Funding detailFunding overview
Funding rounds3 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Murata Vios M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Murata Vios
What does Murata Vios do?
Murata Vios designs, manufactures, and sells the FDA-cleared Vios Monitoring System (VMS), a wireless platform comprising a Chest Sensor, Bedside Monitor, Central Station Monitor, and Central Server (cloud software) that delivers continuous 7-lead ECG, heart rate, respiratory rate, SpO2, pulse rate, posture, and Continuous Non-Invasive Blood Pressure (CNIBP) monitoring in post-acute care settings. The company also operates the Vios Monitoring Program — combining the hardware platform with 24/7 remote monitoring by AHA-certified ECG technicians — and offers separate Remote Monitoring Services to offload alarm surveillance from clinical staff in skilled nursing facilities, inpatient rehabilitation hospitals, ketamine clinics, and hospitals.
Is Murata Vios a public or private company?
Murata Vios is a private company. It is classified as corporate owned and is currently operating.
When was Murata Vios founded?
Murata Vios was founded in 2012. It employs 11 to 50 people.
Where is Murata Vios based?
Murata Vios is headquartered in Saint Paul, United States, in the North America region.
How does Murata Vios make money?
Three revenue lines are on record. Subscription/Monitoring Services are the primary driver. The others are hardware Sales and remote Patient Monitoring (RPM) Reimbursement.
Who are Murata Vios's main competitors?
Direct peers on record are Masimo, VitalConnect, EarlySense and Sotera Wireless (ViSi Mobile). Broad incumbents are Philips (Patient Monitoring), Mindray, Nihon Kohden, Medtronic (Cardiac Diagnostics), GE HealthCare (CARESCAPE) and Baxter (Hillrom / Voalte).
Does Murata Vios have an API?
No public API is recorded for Murata Vios.
What industry is Murata Vios in?
Murata Vios's product category is Wireless Patient Monitoring (Medical Devices). Its primary akta.pro industry code is HLACAPAI, Clinical-Grade Vital Signs Monitoring (ECG, SpO2, BP, Temp, Respiration), with a secondary code of HLAHACAA, Vital Signs Monitoring (Multi-parameter, Spot-Check & Continuous). Its NAICS code is 334510 and its SIC code is 3845.